Other OTC - Delayed Quote • USD
Allergy Therapeutics plc (AGYTF)
As of March 25 at 10:37 AM EDT. Market Open.
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
59,587.0000
59,587.0000
72,768.0000
84,331.0000
78,204.0000
Cost of Revenue
26,342.0000
26,342.0000
23,262.0000
22,106.0000
20,201.0000
Gross Profit
33,245.0000
33,245.0000
49,506.0000
62,225.0000
58,003.0000
Operating Expense
68,149.0000
68,149.0000
61,751.0000
58,194.0000
49,694.0000
Operating Income
-34,904.0000
-34,904.0000
-12,245.0000
4,031.0000
8,309.0000
Net Non Operating Interest Income Expense
-2,112.0000
-2,112.0000
-412.0000
-374.0000
-238.0000
Pretax Income
-41,766.0000
-41,766.0000
-12,657.0000
3,657.0000
8,071.0000
Tax Provision
1,305.0000
1,305.0000
1,119.0000
771.0000
1,013.0000
Net Income Common Stockholders
-43,071.0000
-43,071.0000
-13,776.0000
2,886.0000
7,058.0000
Diluted NI Available to Com Stockholders
-43,071.0000
-43,071.0000
-13,776.0000
2,886.0000
7,058.0000
Basic EPS
-0.06
-0.08
-0.02
0.00
0.01
Diluted EPS
-0.06
-0.08
-0.02
0.00
0.01
Basic Average Shares
670,355.0000
670,355.0000
642,990.0000
639,190.0000
636,169.0000
Diluted Average Shares
670,355.0000
670,355.0000
642,990.0000
676,658.0000
673,492.0000
Total Operating Income as Reported
-39,654.0000
-39,654.0000
-12,245.0000
4,031.0000
8,309.0000
Total Expenses
94,491.0000
94,491.0000
85,013.0000
80,300.0000
69,895.0000
Net Income from Continuing & Discontinued Operation
-43,071.0000
-43,071.0000
-13,776.0000
2,886.0000
7,058.0000
Normalized Income
-39,223.5000
-39,223.5000
-13,776.0000
2,886.0000
7,058.0000
Interest Income
329.0000
329.0000
254.0000
107.0000
261.0000
Interest Expense
2,441.0000
2,441.0000
669.0000
491.0000
504.0000
Net Interest Income
-2,112.0000
-2,112.0000
-412.0000
-374.0000
-238.0000
EBIT
-39,325.0000
-39,325.0000
-11,988.0000
4,148.0000
8,575.0000
EBITDA
-35,101.0000
-35,101.0000
-7,822.0000
8,280.0000
12,489.0000
Reconciled Cost of Revenue
26,342.0000
26,342.0000
23,262.0000
22,106.0000
20,201.0000
Reconciled Depreciation
4,224.0000
4,224.0000
4,166.0000
4,132.0000
3,914.0000
Net Income from Continuing Operation Net Minority Interest
-43,071.0000
-43,071.0000
-13,776.0000
2,886.0000
7,058.0000
Total Unusual Items Excluding Goodwill
-4,750.0000
-4,750.0000
--
--
--
Total Unusual Items
-4,750.0000
-4,750.0000
--
--
--
Normalized EBITDA
-30,351.0000
-30,351.0000
-7,822.0000
8,280.0000
12,489.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0001
Tax Effect of Unusual Items
-902.5000
-902.5000
--
--
--
6/30/2020 - 2/3/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade